Fei Huang

Title: Discovering Innovations by Inventor Fei Huang

Introduction

Fei Huang is a prominent inventor based in Princeton, NJ, known for his significant contributions to medical research and treatment methodologies. With a total of three patents to his name, his work primarily focuses on biomarkers and polynucleotides that play crucial roles in cancer treatment and understanding drug responses.

Latest Patents

Fei Huang's latest patents reflect his innovative approach towards enhancing therapeutic responses in cancer treatment. One of his notable inventions is titled "Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators." This patent outlines a method for identifying and monitoring mammals responding therapeutically to cancer treatments involving IGF1R modulators. The method encompasses exposing a mammal to the modulator and measuring biomarker levels to determine therapeutic responses effectively.

Another significant patent identifies polynucleotides linked to predicting the activity of compounds that interact with protein tyrosine kinases in breast cells. This invention provides essential insights into the relative sensitivity or resistance of various breast cell lines to treatments, contributing significantly to prognostic and diagnostic efforts, especially in the management of breast cancer.

Career Highlights

Fei Huang is associated with Bristol-Myers Squibb Company, where he integrates his research expertise with practical applications in drug development and cancer treatment strategies. His career has been marked by a strong focus on innovations that address critical challenges in oncology, positioning him as a key figure in his field.

Collaborations

Throughout his career, Huang has collaborated with esteemed colleagues, including Xia Han and Karen A Reeves. These partnerships have further advanced his research, fostering a collaborative environment that encourages the sharing of ideas and innovations in the quest to improve therapeutic outcomes.

Conclusion

In summary, Fei Huang's inventive endeavors exemplify the potential of scientific research in transforming cancer treatment. His patents not only advance our understanding of biomarkers and polynucleotides but also pave the way for enhanced therapeutic strategies. As he continues to work at Bristol-Myers Squibb Company, Huang's contributions are sure to make a lasting impact on cancer research and treatment methodologies.